seed
Stage
About
Vivifi Medical is developing ReFlow, a non-surgical outpatient medical procedure to treat benign prostatic hyperplasia (BPH) by addressing the root cause rather than only symptoms. The company is in early clinical development of a non-transurethral technology intended to provide long-term symptom relief with low recurrence and minimal sexual side effects.
Explore Vivifi Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.